Armistice Capital, LLC 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Armistice Capital, LLC disclosed 318 US equity positions worth $3.2bn in its Q3 2025 13F filing. The largest position was PTCT at 6.3% of the reported book, followed by TVTX and SUPN. Against the Q2 2025 filing, it opened 5 new positions, added to 27 and reduced 15 among the top 50 holdings.
What did Armistice Capital, LLC own in Q3 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | PTCT PTC THERAPEUTICS ORD | Healthcare | 6.3% | $201.1m | 3,277,272 | -31% | reduced |
| 2 | TVTX TRAVERE THERAPEUTICS ORD | Healthcare | 5.0% | $160.7m | 6,724,000 | -24% | reduced |
| 3 | SUPN SUPERNUS PHARMACEUTICALS ORD | Healthcare | 4.3% | $135.5m | 2,836,000 | -41% | reduced |
| 4 | INCY INCYTE ORD | Healthcare | 3.1% | $99.0m | 1,167,431 | -13% | reduced |
| 5 | NBIX NEUROCRINE BIOSCIENCES ORD | Healthcare | 3.1% | $97.8m | 697,022 | 3% | added |
| 6 | IMVT IMMUNOVANT ORD | Healthcare | 3.0% | $94.1m | 5,836,000 | 12% | added |
| 7 | XRAY DENTSPLY SIRONA ORD | Healthcare | 2.3% | $72.8m | 5,736,000 | 1044% | added |
| 8 | REGN REGENERON PHARMACEUTICALS ORD | Healthcare | 2.2% | $70.4m | 125,206 | 25% | added |
| 9 | FRPT FRESHPET ORD | Consumer Defensive | 2.1% | $68.0m | 1,234,802 | 118% | added |
| 10 | AMZN AMAZON COM ORD | Consumer Cyclical | 2.1% | $67.9m | 309,400 | 41% | added |
| 11 | CYTK CYTOKINETICS ORD | Healthcare | 2.1% | $65.8m | 1,196,868 | -9% | reduced |
| 12 | GEHC GE HEALTHCARE TECHNOLOGIES ORD | Healthcare | 1.9% | $59.7m | 795,053 | 5% | added |
| 13 | EXK EXACT SCIENCES ORD | Basic Materials | 1.8% | $56.4m | 1,030,465 | 39% | added |
| 14 | GOOGL ALPHABET CL A ORD | Communication Services | 1.8% | $56.1m | 230,681 | 21% | added |
| 15 | MDGL MADRIGAL PHARMACEUTICALS ORD | Healthcare | 1.7% | $55.0m | 119,982 | -3% | reduced |
| 16 | FIVN FIVE9 ORD | Technology | 1.5% | $48.4m | 2,000,000 | 9% | added |
| 17 | MSFT MICROSOFT ORD | Technology | 1.4% | $45.2m | 87,245 | 4% | added |
| 18 | ARGX ARGENX ADR REP ORD | Healthcare | 1.3% | $42.8m | 58,000 | -28% | reduced |
| 19 | TMCI TREACE MEDICAL CONCEPTS ORD | Healthcare | 1.3% | $42.4m | 6,316,000 | 1% | added |
| 20 | KURA KURA ONCOLOGY ORD | Healthcare | 1.3% | $41.3m | 4,672,000 | -25% | reduced |
| 21 | NVO NOVO NORDISK ADR REPSG 1 ORD | Healthcare | 1.3% | $40.8m | 736,000 | – | new |
| 22 | PENN PENN ENTERTAINMENT ORD | Consumer Cyclical | 1.3% | $40.5m | 2,103,666 | 49% | added |
| 23 | DYN DYNE THERAPEUTICS ORD | Healthcare | 1.2% | $38.8m | 3,064,000 | 20% | added |
| 24 | MDB MONGODB CL A ORD | Technology | 1.1% | $34.9m | 112,399 | 9% | added |
| 25 | OFIX ORTHOFIX MEDICAL ORD | Healthcare | 1.0% | $32.7m | 2,236,000 | -25% | reduced |
| 26 | AGIO AGIOS PHARMACEUTICALS ORD | Healthcare | 1.0% | $30.7m | 764,000 | -35% | reduced |
| 27 | SBUX STARBUCKS ORD | Consumer Cyclical | 0.9% | $30.1m | 356,107 | – | new |
| 28 | IMCR IMMUNOCORE HOLDINGS ADR | Healthcare | 0.9% | $29.9m | 824,000 | 22% | added |
| 29 | BMY BRISTOL MYERS SQUIBB ORD | Healthcare | 0.9% | $29.3m | 649,733 | – | new |
| 30 | 8HH AVANOS MEDICAL ORD | 0.9% | $28.9m | 2,500,000 | 23% | added | |
| 31 | SNY SANOFI 2 ADR REP ORD | 0.9% | $28.9m | 612,000 | – | new | |
| 32 | IRON DISC MEDICINE ORD | Healthcare | 0.9% | $28.8m | 436,000 | 0% | held |
| 33 | DDOG DATADOG CL A ORD | Technology | 0.9% | $28.8m | 202,061 | 35% | added |
| 34 | BABA ALIBABA GROUP HOLDING ADR REP 8 ORD | Consumer Cyclical | 0.9% | $27.9m | 156,000 | 169% | added |
| 35 | TMO THERMO FISHER SCIENTIFIC ORD | Healthcare | 0.8% | $26.7m | 55,016 | 84% | added |
| 36 | AUTL AUTOLUS THERAPEUTICS ADR | Healthcare | 0.8% | $25.4m | 15,600,000 | 30% | added |
| 37 | MDT MEDTRONIC ORD | Healthcare | 0.8% | $25.3m | 265,257 | 0% | held |
| 38 | NBIS NEBIUS CL A ORD | Communication Services | 0.8% | $23.9m | 213,280 | 72% | added |
| 39 | BCYC BICYCLE THERAPEUTICS ADR | Healthcare | 0.7% | $23.0m | 2,978,000 | 6% | added |
| 40 | GRFS GRIFOLS ADR REP ONE NON VTG CL B ORD | Healthcare | 0.7% | $22.3m | 2,236,000 | -69% | reduced |
| 41 | CVS CVS HEALTH ORD | Healthcare | 0.7% | $22.0m | 291,819 | – | new |
| 42 | AXGN AXOGEN ORD | Healthcare | 0.7% | $21.4m | 1,200,000 | 8% | added |
| 43 | IRWD IRONWOOD PHARMA CL A ORD | Healthcare | 0.7% | $21.2m | 16,150,000 | 0% | held |
| 44 | HUBS HUBSPOT ORD | Technology | 0.7% | $21.1m | 45,018 | 104% | added |
| 45 | RIGL RIGEL PHARMACEUTICALS ORD | 0.6% | $20.5m | 724,000 | -55% | reduced | |
| 46 | VYGR VOYAGER THERAPEUTICS ORD | Healthcare | 0.6% | $19.6m | 4,200,000 | -12% | reduced |
| 47 | S SENTINELONE CL A ORD | Technology | 0.6% | $19.6m | 1,111,200 | -10% | reduced |
| 48 | DT DYNATRACE ORD | Technology | 0.6% | $19.4m | 400,000 | 79% | added |
| 49 | MLYS MINERALYS THERAPEUTICS ORD | Healthcare | 0.6% | $19.3m | 507,650 | 185% | added |
| 50 | VSTM VERASTEM ORD | Healthcare | 0.6% | $18.5m | 2,096,000 | -2% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.